Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 7/20 | 0.43 |
| ▸ | MAOB | P27338 | 4/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16281728 | 1.00 | FFAR1 (0.43) | FFAR1MAOBS1PR1S1PR5SRD5A1 | |
| SCHEMBL10187560 | 0.94 | FFAR1 (0.43) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL10187572 | 0.87 | FFAR1 (0.42) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL10187547 | 0.83 | FFAR1 (0.41) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL13262087 | 0.83 | FFAR1 (0.41) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL515347 | 0.76 | SRD5A1 (0.41) | MAOBS1PR1S1PR5SRD5A1MEN1 | |
| SCHEMBL10192897 | 0.72 | BRD4 (0.51) | FFAR1MAOBMEN1KMT2ABRD4 | |
| SCHEMBL13261915 | 0.72 | FFAR1 (0.39) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL515151 | 0.72 | FFAR1 (0.41) | FFAR1MAOBS1PR1S1PR5MEN1 | |
| SCHEMBL516169 | 0.69 | MAOB (0.41) | MAOBS1PR1S1PR5SRD5A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680339-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2014-03-25 | — | — | US | disclosed |
| US-8680339-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2014-03-25 | — | — | US | disclosed |
| US-20120028800-A1 | NOVEL HERBICIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028800-A1 | NOVEL HERBICIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028800-A1 | NOVEL HERBICIDES | DDT, CYP4X1, CYP1B1 | FFAR1 752/4885MAOB 2064/4885S1PR1 3494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.